Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies
Share this:
Published: 25 Jul 2016

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose diseases.” Biologic drugs are significantly derived from monoclonal antibodies, recombinant proteins, vaccines, and others (e.g., cell therapy, gene therapy, antibody drug conjugates). In this study, drivers, restraints, and the competitive landscape as well as outsourcing and market and technology trends are discussed. Estimates and forecasts for the global market are provided from 2016 to 2020.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  

Search Terms

42 sections of this document (indicated by ...) contain search terms

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..